For comparison, in thyroid cancer, ovarian cancer, brain glioma, glioblastoma, and colon adenocarcinoma, where ZnT1 transcript levels were not significantly different, patient survival rates did not differ (Fig. 2c). The gene discussed is SLC30A1; the disease is ovarian cancer.